cholestyramine resin has been researched along with Bone Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, R; Shinozaki, T; Takagishi, K; Tomidokoro, R; Watanabe, H; Yamamoto, K | 1 |
| Falletta, JM; Moncino, MD | 1 |
2 other study(ies) available for cholestyramine resin and Bone Neoplasms
| Article | Year |
|---|---|
Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
Topics: Anion Exchange Resins; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Cholestyramine Resin; Humans; Kidney; Liver; Male; Methotrexate; Osteosarcoma; Tibia; Time Factors; Treatment Outcome | 2000 |
Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy.
Topics: Adolescent; Agranulocytosis; Bone Neoplasms; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Osteosarcoma; Recurrence; Time Factors | 1992 |